QUFLORA FE (pediatric multivitamin no.151/ferrous sulfate/sod fluoride)
FLUORIDES · VITAMIN DEFICIENCY ·+3
CARWIN ASSOCIAT
Drug class
Iron
The term iron typically refers to the essential trace mineral rather than an isolated pharmacological drug class; however, in therapeutic classifications by regulatory agencies and biomedical compendia, therapeutic iron formulations are recognized under the class of hematinics or iron replacement products. Read more about Iron
368 drugs in this class 107 manufacturers
Drugs in Iron
FERROUS SULFATE
IRON · IRON DEFICIENCY ANEMIA
WESTMINSTER PHA
FERROUS SULFATE
IRON · IRON DEFICIENCY ANEMIA
WAL-MART STORES
FERROUS GLUCONATE
IRON · IRON DEFICIENCY ANEMIA
LEADER
FERROUS SULFATE
IRON · IRON DEFICIENCY ANEMIA
PHARBEST PHARMA
FERROUS SULFATE
IRON · IRON DEFICIENCY ANEMIA
SILARX/LANNETT
FERROUS SULFATE
IRON · IRON DEFICIENCY ANEMIA
SILARX/LANNETT
DINO-LIFE (pediatric multivitamin no.159/ferrous sulfate)
IRON · VITAMIN DEFICIENCY ·+3
NAT'L VIT. CO.
CHILD COMPLETE CHEWABLE VITAMN (pediatric multivitamin no.140/ferrous fumarate)
IRON · VITAMIN DEFICIENCY ·+3
RITE AID CORP.
Filter & compare in the drug finder →
Opens the drug finder with Iron preselected. Add indication or manufacturer filters there.
The term iron typically refers to the essential trace mineral rather than an isolated pharmacological drug class; however, in therapeutic classifications by regulatory agencies and biomedical compendia, therapeutic iron formulations are recognized under the class of hematinics or iron replacement products.
These agents function by replenishing depleted systemic iron stores to support normal erythropoiesis, hemoglobin synthesis, cellular energy metabolism, and oxygen transport throughout the body.
They are principally indicated for the prevention and treatment of iron deficiency and iron deficiency anemia resulting from chronic blood loss, malnutrition, malabsorption, pregnancy, or increased demand.
Additionally, parenteral iron formulations are widely utilized to manage iron deficiency in specialized clinical disease states, notably chronic kidney disease (often in patients undergoing hemodialysis or receiving erythropoiesis-stimulating agents) and heart failure.
-
fda.gov
The term iron typically refers to the essential trace mineral rather than an isolated pharmacological drug class; however, in therapeutic classifications by regulatory agencies and biomedical compendia, therapeutic iron formulations are recognized under the class of hematinics or iron replacement products These agents function by replenishing depleted systemic iron stores to support normal erythropoiesis, hemoglobin synthesis, cellular energy metabolism, and oxygen transport throughout the body
-
fda.gov
The term iron typically refers to the essential trace mineral rather than an isolated pharmacological drug class; however, in therapeutic classifications by regulatory agencies and biomedical compendia, therapeutic iron formulations are recognized under the class of hematinics or iron replacement products
-
nih.gov
The term iron typically refers to the essential trace mineral rather than an isolated pharmacological drug class; however, in therapeutic classifications by regulatory agencies and biomedical compendia, therapeutic iron formulations are recognized under the class of hematinics or iron replacement products
-
fda.gov
These agents function by replenishing depleted systemic iron stores to support normal erythropoiesis, hemoglobin synthesis, cellular energy metabolism, and oxygen transport throughout the body
-
nih.gov
They are principally indicated for the prevention and treatment of iron deficiency and iron deficiency anemia resulting from chronic blood loss, malnutrition, malabsorption, pregnancy, or increased demand
-
nih.gov
They are principally indicated for the prevention and treatment of iron deficiency and iron deficiency anemia resulting from chronic blood loss, malnutrition, malabsorption, pregnancy, or increased demand
-
fda.gov
Additionally, parenteral iron formulations are widely utilized to manage iron deficiency in specialized clinical disease states, notably chronic kidney disease (often in patients undergoing hemodialysis or receiving erythropoiesis-stimulating agents) and heart failure
-
nih.gov
Additionally, parenteral iron formulations are widely utilized to manage iron deficiency in specialized clinical disease states, notably chronic kidney disease (often in patients undergoing hemodialysis or receiving erythropoiesis-stimulating agents) and heart failure
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.